Search
for
Sort by
Research 91–120 of 1000+
- Association of alopecia areata with COVID-19 vaccination: A vaccine adverse events reporting system analysis
- Evaluation of dermatologic adverse events associated with aromatase inhibitors: insights from the FAERS database
- The pharmacovigilance analysis of adverse events of erlotinib based on the open access FAERS database
- Dermatologic adverse events associated with chemotherapy and targeted anticancer therapy
- Adverse events associated with vismodegib: insights from a real-world pharmacovigilance study using the FAERS database
- Dermatological adverse events with taxane chemotherapy
- Safety Profile of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: A Disproportionality Analysis of FDA Adverse Event Reporting System
- Signal Mining for Non-Bleeding Adverse Event in Novel Oral Anticoagulants: A Pharmacovigilance Study Based on the FAERS Database
- Burden of immune-related skin diseases worldwide, 1991–2021: insights and prediction from the Global Burden of Disease Study
- Neutralization of IL-8 Prevents the Induction of Dermatologic Adverse Events Associated with the Inhibition of Epidermal Growth Factor Receptor
- Developing a JAK Inhibitor for Targeted Local Delivery: Ruxolitinib Cream
- The JAK/STAT signaling pathway: from bench to clinic
- Efficacy and safety of trastuzumab deruxtecan in the treatment of HER2-low/positive advanced breast cancer: a single-arm meta-analysis
- Laser-Assisted Exosome Delivery (LAED) with Fractional CO2 Laser: A Pilot Two-Case Report and Narrative Review
- The Administration of Ocoxin Increases the Quality of Life of Patients with Advanced Epithelial or Metastatic Ovarian Cancer Undergoing Neoadjuvant Chemotherapy
- Sex- or Gender-specific Differences in the Clinical Presentation, Outcome, and Treatment of SARS-CoV-2
- Comprehensive Safety Exposure‐Response Analysis to Support Ritlecitinib Dose Selection
- Olink proteomics analysis of scalp psoriasis reveals a cytokine storm inflammatory mainly related to bacterial-derived antigens
- A case of alopecia areata after rabies vaccination: unreported adverse effect?
- 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibition Attenuates the Adverse Effects of Glucocorticoids on Dermal Papilla Cells
- Evaluation of the efficacy and treatment-emergent adverse events of deuruxolitinib for moderate to severe alopecia areata: a dose-ranging meta-analysis of 1,372 randomized patients
- Novel therapies for alopecia areata: The era of rational drug development
- Integrated safety analysis of baricitinib in adults with severe alopecia areata from two randomized clinical trials
- Cutaneous adverse events to systemic antineoplastic therapies: a retrospective study in a public oncologic hospital
- Dermatologic Care of the Transplant Patient
- Cyclosporine-induced alopecia:a case report, FDA adverse event reporting system analysis and literature assessment
- Identification and characterization of four immune-related signatures in keloid
- Adverse events of the thyroid peroxidase inhibitor methimazole in the treatment of hyperthyroidism: a comprehensive analysis from the first quarter of 2004 to the first quarter of 2025
- Assessing the real-world safety of tralokinumab for atopic dermatitis: insights from a comprehensive analysis of FAERS data
- A disproportionality analysis of adverse events caused by pexidartinib from the FDA adverse event reporting system